pI: 9.0884 |
Length (AA): 602 |
MW (Da): 64676 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 9 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
139 | 375 | 2a7k (A) | 2 | 230 | 15.00 | 0 | 1 | 0.53 | -0.5 |
141 | 352 | 1xx4 (A) | 35 | 246 | 18.00 | 0 | 0.99 | 0.63 | -0.65 |
107 | 345 | 3lke (A) | 5 | 225 | 22.00 | 0 | 1 | 0.61281 | -0.33 |
109 | 602 | 5jbx (A) | 3 | 258 | 41.00 | 0 | 1 | 0.180298 | 2.21 |
116 | 602 | 2pbp (A) | 13 | 258 | 41.00 | 0.000000000012 | 1 | 0.14567 | 1.54 |
119 | 232 | 5c9g (A) | 14 | 125 | 35.00 | 0.0000000026 | 1 | 0.661069 | -0.81 |
361 | 414 | 2wtb (A) | 134 | 187 | 48.00 | 0.000064 | 1 | 0.680401 | -0.2 |
364 | 412 | 2ppy (A) | 137 | 185 | 47.00 | 0.0000057 | 1 | 0.691095 | -0.49 |
563 | 602 | 3r9t (A) | 224 | 263 | 33.00 | 0.027 | 0.02 | 0.549845 | -1.63 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | ME49 Tachyzoite. | Gregory |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Ortholog group members (OG5_128987)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G16800 | ATP-dependent caseinolytic (Clp) protease/crotonase family protein |
Caenorhabditis elegans | CELE_F56B3.5 | Protein ECH-5 |
Dictyostelium discoideum | DDB_G0289471 | enoyl-CoA hydratase/isomerase domain-containing protein |
Drosophila melanogaster | Dmel_CG8778 | CG8778 gene product from transcript CG8778-RA |
Homo sapiens | ENSG00000148090 | AU RNA binding protein/enoyl-CoA hydratase |
Homo sapiens | ENSG00000121310 | enoyl CoA hydratase domain containing 2 |
Leishmania braziliensis | LbrM.34.0400 | enoyl-CoA hydratase/isomerase family protein, conserved |
Leishmania donovani | LdBPK_350360.1 | enoyl-CoA hydratase/isomerase family protein, conserved |
Leishmania infantum | LinJ.35.0360 | enoyl-CoA hydratase/isomerase family protein, conserved |
Leishmania major | LmjF.35.0360 | enoyl-CoA hydratase/isomerase family protein, conserved |
Leishmania mexicana | LmxM.34.0360 | enoyl-CoA hydratase/isomerase family protein, conserved |
Mus musculus | ENSMUSG00000028601 | enoyl Coenzyme A hydratase domain containing 2 |
Mus musculus | ENSMUSG00000021460 | AU RNA binding protein/enoyl-coenzyme A hydratase |
Neospora caninum | NCLIV_022740 | enoyl-CoA hydratase/isomerase family protein, putative |
Oryza sativa | 4330183 | Os02g0654000 |
Oryza sativa | 4330184 | Os02g0654100 |
Schmidtea mediterranea | mk4.005506.00 | |
Trypanosoma brucei gambiense | Tbg972.10.5000 | methylglutaconyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.10.4000 | methylglutaconyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma congolense | TcIL3000_10_3330 | methylglutaconyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.510997.40 | enoyl-CoA hydratase/isomerase family protein, putative |
Trypanosoma cruzi | TcCLB.506959.40 | enoyl-CoA hydratase/isomerase family protein, putative |
Toxoplasma gondii | TGME49_202140 | enoyl-CoA hydratase/isomerase family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.4000 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.4000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.4000 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.4000 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_202140 this record | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.